vs
Side-by-side financial comparison of GAIA, INC (GAIA) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $25.5M, roughly 1.6× GAIA, INC). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -0.3%, a 36.2% gap on every dollar of revenue. On growth, GAIA, INC posted the faster year-over-year revenue change (5.8% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $76.0K). Over the past eight quarters, GAIA, INC's revenue compounded faster (9.4% CAGR vs -15.0%).
Gaia, Inc. is a publicly traded (NASDAQ:GAIA) American media company founded in 1988 by Jirka Rysavy in Louisville, Colorado. It owns and operates Gaia TV, a subscription video on-demand service consisting of original and licensed alternative media documentaries, including those on wellness, spirituality and conspiracy theories.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
GAIA vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $39.6M |
| Net Profit | $-75.0K | $14.2M |
| Gross Margin | 87.6% | 73.1% |
| Operating Margin | -2.6% | 32.5% |
| Net Margin | -0.3% | 35.9% |
| Revenue YoY | 5.8% | -10.9% |
| Net Profit YoY | 91.7% | 117.2% |
| EPS (diluted) | $-0.02 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $39.6M | ||
| Q3 25 | $25.0M | $43.4M | ||
| Q2 25 | $24.6M | $43.4M | ||
| Q1 25 | $23.8M | $47.3M | ||
| Q4 24 | $24.1M | $44.4M | ||
| Q3 24 | $22.0M | $53.1M | ||
| Q2 24 | $21.9M | $53.1M | ||
| Q1 24 | $21.3M | $54.8M |
| Q4 25 | $-75.0K | $14.2M | ||
| Q3 25 | $-1.2M | $12.8M | ||
| Q2 25 | $-2.0M | $2.5M | ||
| Q1 25 | $-1.2M | $21.5M | ||
| Q4 24 | $-907.0K | $6.5M | ||
| Q3 24 | $-1.2M | $2.8M | ||
| Q2 24 | $-2.2M | $18.5M | ||
| Q1 24 | $-971.0K | $18.8M |
| Q4 25 | 87.6% | 73.1% | ||
| Q3 25 | 86.4% | 70.6% | ||
| Q2 25 | 86.7% | 69.2% | ||
| Q1 25 | 87.7% | 79.7% | ||
| Q4 24 | 88.2% | 76.3% | ||
| Q3 24 | 86.1% | 81.5% | ||
| Q2 24 | 84.5% | 74.2% | ||
| Q1 24 | 85.3% | 72.1% |
| Q4 25 | -2.6% | 32.5% | ||
| Q3 25 | -5.0% | 36.6% | ||
| Q2 25 | -8.9% | 33.6% | ||
| Q1 25 | -4.3% | 51.1% | ||
| Q4 24 | -7.1% | 10.6% | ||
| Q3 24 | -5.3% | 26.1% | ||
| Q2 24 | -9.1% | 51.4% | ||
| Q1 24 | -4.0% | 44.6% |
| Q4 25 | -0.3% | 35.9% | ||
| Q3 25 | -4.6% | 29.6% | ||
| Q2 25 | -8.3% | 5.7% | ||
| Q1 25 | -5.1% | 45.4% | ||
| Q4 24 | -3.8% | 14.7% | ||
| Q3 24 | -5.4% | 5.3% | ||
| Q2 24 | -9.9% | 34.8% | ||
| Q1 24 | -4.6% | 34.2% |
| Q4 25 | $-0.02 | $0.15 | ||
| Q3 25 | $-0.05 | $0.12 | ||
| Q2 25 | $-0.07 | $0.02 | ||
| Q1 25 | $-0.04 | $0.21 | ||
| Q4 24 | $-0.03 | $0.05 | ||
| Q3 24 | $-0.05 | $0.03 | ||
| Q2 24 | $-0.09 | $0.20 | ||
| Q1 24 | $-0.05 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.5M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $87.9M | $248.3M |
| Total Assets | $154.6M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.5M | $164.1M | ||
| Q3 25 | $14.2M | $127.4M | ||
| Q2 25 | $13.9M | $152.7M | ||
| Q1 25 | $13.1M | $132.1M | ||
| Q4 24 | $5.9M | $125.0M | ||
| Q3 24 | $4.4M | $137.4M | ||
| Q2 24 | $5.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $87.9M | $248.3M | ||
| Q3 25 | $86.3M | $248.0M | ||
| Q2 25 | $85.7M | $244.6M | ||
| Q1 25 | $87.0M | $226.4M | ||
| Q4 24 | $80.7M | $195.1M | ||
| Q3 24 | $81.2M | $205.0M | ||
| Q2 24 | $82.1M | $8.8M | ||
| Q1 24 | $84.8M | $9.0M |
| Q4 25 | $154.6M | $380.4M | ||
| Q3 25 | $151.1M | $321.4M | ||
| Q2 25 | $147.0M | $315.3M | ||
| Q1 25 | $148.5M | $284.6M | ||
| Q4 24 | $141.2M | $266.1M | ||
| Q3 24 | $139.6M | $296.5M | ||
| Q2 24 | $142.1M | $19.5M | ||
| Q1 24 | $133.8M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $52.0M |
| Free Cash FlowOCF − Capex | $76.0K | $51.2M |
| FCF MarginFCF / Revenue | 0.3% | 129.3% |
| Capex IntensityCapex / Revenue | 6.6% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.0K | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.8M | $52.0M | ||
| Q3 25 | $326.0K | $-20.9M | ||
| Q2 25 | $2.3M | $-8.3M | ||
| Q1 25 | $1.3M | $1.9M | ||
| Q4 24 | $2.7M | $-7.3M | ||
| Q3 24 | $409.0K | $5.0M | ||
| Q2 24 | $-2.1M | $19.2M | ||
| Q1 24 | $5.9M | $3.7M |
| Q4 25 | $76.0K | $51.2M | ||
| Q3 25 | $-1.6M | $-20.9M | ||
| Q2 25 | $880.0K | $-8.6M | ||
| Q1 25 | $268.0K | $1.7M | ||
| Q4 24 | $1.6M | $-7.9M | ||
| Q3 24 | $-952.0K | $4.6M | ||
| Q2 24 | $-3.5M | $18.3M | ||
| Q1 24 | $4.9M | $3.0M |
| Q4 25 | 0.3% | 129.3% | ||
| Q3 25 | -6.4% | -48.3% | ||
| Q2 25 | 3.6% | -19.9% | ||
| Q1 25 | 1.1% | 3.5% | ||
| Q4 24 | 6.5% | -17.8% | ||
| Q3 24 | -4.3% | 8.7% | ||
| Q2 24 | -16.1% | 34.5% | ||
| Q1 24 | 22.8% | 5.4% |
| Q4 25 | 6.6% | 2.0% | ||
| Q3 25 | 7.7% | 0.1% | ||
| Q2 25 | 5.7% | 0.7% | ||
| Q1 25 | 4.3% | 0.5% | ||
| Q4 24 | 4.6% | 1.3% | ||
| Q3 24 | 6.2% | 0.8% | ||
| Q2 24 | 6.6% | 1.6% | ||
| Q1 24 | 5.0% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GAIA
| US | $16.7M | 65% |
| Non Us | $8.8M | 35% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
